Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.
about
In vitro comparative models for canine and human breast cancersEnhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell linesStrategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.Exploiting cancer genomics in pet animals to gain advantage for personalized medicine decisions.3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma.Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.Prolactin and growth hormone immunoactivity in canine mammary adenomas and adenocarcinomas.Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model.Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity.
P2860
Q26752714-35A2D5E2-BC1A-49F9-80CA-6829B41E19C9Q28546881-DDB27095-66FB-4022-8517-9A35658EADBEQ30366921-FB05AE28-E84C-40C9-BD32-F275FA715B9EQ33917501-1F11BCF9-3D8D-456B-B8EB-E321D8B20B65Q36604036-AE802C18-33DF-4BB4-9229-E29245EB5C39Q36919383-D441B93D-241E-4C1D-AB73-034D05A980F9Q38718417-4BE90D23-E8B9-46FF-9B30-104C72D2C16DQ38773516-15C9C052-982E-4996-8599-C97076A65075Q39251469-9549545C-7175-4FC7-98A8-401F888D9022Q43185759-C30803BD-B0AF-444B-86F6-AB600DE09FBCQ45641138-C122B393-3EBB-4A37-A3EF-10BF5FC1D636Q47100454-6E0CE591-393B-4D4A-A8EF-A5BFE5C1FFE4Q47907482-DBC32DEE-68CB-44E7-84C0-9C08135D093CQ50001909-E2DA9A72-5ACD-4AF6-AF18-BE8E230661C9Q55000921-92BA7234-3C35-40F7-B61C-3EBA47952887
P2860
Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@ast
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@en
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@nl
type
label
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@ast
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@en
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@nl
prefLabel
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@ast
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@en
Expression and role of PGP, BC ...... f canine mammary cancer cells.
@nl
P2093
P2860
P356
P1476
Expression and role of PGP, BC ...... of canine mammary cancer cells
@en
P2093
Joanna Mucha
Magdalena Król
Tomasz Motyl
P2860
P2888
P356
10.1186/1746-6148-9-119
P577
2013-06-17T00:00:00Z
P5875
P6179
1034935636